mayo clinic glp-1 oral solution GLP-1s have continued to dominate the headlines. But are they everything we hoped for?, On this podcast episode of Health Matters, dietitian Tara Schmidt breaks down the biggest 𝑀𝑎𝑦𝑜 𝐶𝑙𝑖𝑛𝑖𝑐 𝑅𝑒𝑐𝑜𝑚𝑚𝑒𝑛𝑑𝑒𝑑 | 𝑂𝑓𝑓𝑖𝑐𝑖𝑎𝑙

Description

How Will Medicare and Medicaid Coverage Evolve for GLP-1 Drugs in 2025-2026

A study investigate the effects of liraglutide on the advanced glycation end products (AGEs)-induced chronic diabetic complications of bone injury in ApoE / mice

In cases where an employer is providing plan coverage for GLP-1 medications for obesity, there are risks and potential unforeseen consequences if the coverage doesnt have a defined plan structure and a managed process for treatment

Have I discussed GLP-1 medications with my primary care doctor

Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)